Sign up to save your podcasts
Or
Share Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
CME credits: 0.25
Valid until: 15-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2-vegf-a-inhibition-durability-and-drying/18008/
What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 15-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2-vegf-a-inhibition-durability-and-drying/18008/
What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.
=